Freeline Therapeutics Holdings plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.3845 | 33.49 | -101.15% | -0.1109 | +246.81% |
| P/S |
|
30.93 | 129.83 | -76.18% |
|
|
| P/BV |
|
7.81 | 260.15 | -97% |
|
|
| P/FCF |
|
-0.2791 | -180.12 | -99.85% |
|
|
| Ev/Ebitda |
|
-3.78 | -28.84 | -86.88% |
|
|
| Ev/S |
|
591.32 | 548.04 | 7.9% |
|
|
| Ev/FCF |
|
-5.35 | -289.87 | -98.16% |
|
|
| E/P |
|
-2.6 | 0.0228 | -11517.13% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-15627.01 | -375.54 | 4061.21% | -15443.27 | +1.19% |
| ROE |
|
-102.94 | 106.63 | -196.55% |
|
|
| ROA |
|
-78.13 | -2.32 | 3274.5% |
|
|
| ROIC |
|
-57.83 | 0.8343 | -7031.79% |
|
|
| ROS |
|
-8027.65 | -298.59 | 2588.56% |
|
|
| ROCE |
|
-187.79 | 3.17 | -6019.38% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0607 | 0.9426 | -106.44% | -0.0608 | -0.0867% |
| Nеt Debt/Ebitda |
|
0.4259 | 1.04 | -59.22% |
|
|
| Debt/Ratio |
|
0.0681 | 0.1798 | -62.1% |
|
|
| Debt/Equity |
|
0.6527 | 1.62 | -59.7% |
|
|
| Debt/Net Income |
|
-0.1182 | -1.65 | -92.85% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5317 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8182 | -100% | ||
| DSI |
|
0 | 0.2062 | -100% |
|
|
| Average dividend growth |
|
0 | 2.29 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5169 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.77 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5317 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
0.8104 | -99.58 | -100.81% | ||
| Growth impulse Ebitda in 5 years |
|
78.35 | -152.61 | -151.34% | ||
| Growth impulse Net Income in 5 years |
|
-7.53 | -115.25 | -93.47% | ||
| Growth impulse FCF in 5 years |
|
25.08 | -161.2 | -115.56% | ||
| Growth impulse EPS in 5 years |
|
-99.98 | -106.31 | -5.95% |
IP Score
3.03/10
